Coupled with fierce competition in therapeutic areas of greatest return, the entry of non-traditional technology players puts added pressure on Life Sciences companies.
Discover how realistic simulation is changing the medical device industry.
Getting the right therapeutic solution to the right patient, at the right time, at the right price and providing the right customer experience is the ultimate goal for Life Sciences companies…but the challenge in doing this should not be underestimated. The key to developing the right Life Sciences product portfolio is delivering on outcomes and value with an agile approach. This enables you to:
Significantly accelerate time to market
Reduce development costs
Deliver unmatched quality & efficacy
Anticipate & reduce risk with enhanced portfolio management
Learn how Synthetic Controls are enabling new insights for oncology clinical development and streamlines clinical development and mitigates Go/No-go decision risk. Synthetic Control Data can assist disease learning and future trial planning, and Synthetic Control Arm provides precise data for confident interpretation of uncontrolled trials.
Realistic simulation is playing a key role in the development of ever more reliable and effective therapeutic solutions that are promising improved patient experience and quality of life. This is accelerated due to the increasing acceptance of the use of modeling and simulation results as evidence in submissions.
Using the Dassault Systèmes’ 3DEXPERIENCE® platform, Life Sciences organizations are able to create lifelike models of medical devices and human anatomy to replicate in-vitro and in-vivo test environments and conditions, lessening the reliance on physical testing. Individual and populations of patients are defined, modeled and simulated in a virtual environment to capture data that supports regulatory submissions and improves design performance, robustness, patient safety and the patient experience.
With our suite of clinical trial solutions, clinical trials are revolutionized through data continuity on an end-to-end platform environment. Sponsors can optimize their trials with the largest dataset in the world, reduce complexity and risk for all their data and processes, streamline their study workflow and improve productivity, increase operation efficiency and run efficient patient centric studies sponsored by myMedidata.
Discover Dassault Systèmes®' Life Sciences industry solutions aiming to improve patient and physician experience, and organizational business excellence.